| Association Between Polypharmacy, Patient Reported Symptoms, and Quality of Life among Nonalcoholic Fatty Liver Disease Patients in the United States. | | | Journal | 2022 | 10.1007/s40267-022-00957-z | TONIC, PIVENS, NAFLD Pediatric, NAFLD Adult | 23211 | Secondary Research |
| Association of changes in histological severity of non-alcoholic steatohepatitis and changes in patient-reported quality of life | 35903833 | PMC9512481 | Journal | 2022 | 10.1002/hep4.2044 | FLINT, PIVENS | 23138 | Secondary Research |
| Changes in Serum Cytokeratin 18 Levels Significantly Predict Changes in Liver Histology in Adults With Nonalcoholic Steatohepatitis: Results From the Pivens Trial | | | Journal | 2013 | | PIVENS | | Contributing Study |
| Elevated Serum Ferritin Values Above the Upper Limit of Normal Are Associated With Laboratory and Histologic Evidence of Increased NASH Severity, but Not the Presence of Diabetes or Metabolic Syndrome Among Patients in the NASH CRN | | | Journal | 2011 | | PIVENS | | Contributing Study |
| Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials. | 24759732 | PMC3997354 | Journal | 2014 | 10.1371/journal.pone.0095366 | TONIC, PIVENS | | Contributing Study |
| Histologic Predictors of Improvement in Fibrosis in NASH: Results from the Clinical Research Network PIVENS Trial | | | Journal | 2012 | | PIVENS | | Contributing Study |
| Metabolomic Profiling to Define Predictors of Response to Vitamin E for Non- Alcoholic Steatohepatitis (NASH) | | | Journal | 2011 | | PIVENS | | Contributing Study |
| Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. | 18804555 | PMC2929909 | Journal | 2009 | 10.1016/j.cct.2008.09.003 | PIVENS | | Contributing Study |
| Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. | 20427778 | PMC2928471 | Journal | 2010 | 10.1056/NEJMoa0907929 | PIVENS | | Contributing Study |
| Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH): What Is the Mechanism? | | | Journal | 2013 | | PIVENS | | Contributing Study |
| The Effect of Polypharmacy on Quality of Life in Adult Patients with Nonalcoholic Fatty Liver Disease in the United States. | 35064417 | | Journal | 2022 | 10.1007/s11136-022-03090-6 | PIVENS, TONIC, NAFLD Adult, NAFLD Pediatric | 23211 | Secondary Research |
| The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis | 37933187 | | Journal | 2024 | 10.1080/03007995.2023.2279676 | PIVENS, CyNCh, TONIC, FLINT, NAFLD Adult, NAFLD Pediatric | 23059 | Secondary Research |
| Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity. | 24849310 | PMC4241186 | Journal | 2015 | 10.1002/hep.27235 | PIVENS | | Contributing Study |
